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Abstract	
A	breach	of	the	skin	barrier,	due	to	a	burn	wound,	facilitates	colonization	by	various	
microorganisms.	Burn	wounds	can	become	colonized	from	the	patients’	own	skin	flora,	
respiratory	tract,	or	with	exogenous	bacteria	from	the	environment.	Strategies	to	treat	burn	
wound	infections	are	multipronged:	removal	of	the	infected	necrotic	tissue,	wound	dressing	to	
protect	the	damaged	area,	and	treatment	with	specific	antimicrobials	to	prevent	reinfection.	
The	development	of	chronic	infections,	which	could	potentially	lead	to	sepsis,	depends	largely	
on	how	well	the	microorganisms	form	biofilms	within	the	wound.	There	are	numerous	
antimicrobial	gels	and	antibiotics	that	help	prevent	a	burn	wound	from	becoming	infected,	as	
well	as,	eliminate	an	already	infected	burn	wound.	However,	global	antibiotic	resistance	by	
microorganisms	to	these	treatments	has	greatly	increased,	and	it	is	imperative	that	new	
antimicrobial	agents	be	formulated	before	infections	become	untreatable.	Staphylococcus,	
Pseudomonas,	Acinetobacter,	Escherichia,	Candida,	Citrobacter,	and	Klebsiella	are	common	
causative	agents	of	burn	wound	infections	and	are	becoming	increasingly	resistant	to	
antimicrobial	medications.	A	newly	synthesized	antimicrobial	gel	compound	(AGC)	has	shown	
promise	in	preventing	growth	of	various	bacteria	and	fungi	commonly	associated	with	burn	
wound	infections.	This	study	evaluated	the	activity	of	the	AGC	on	a	panel	of	Gram-positive	and	
Gram-	negative	bacteria,	and	the	fungi,	Candida	albicans,	which	represent	the	top	ten	causative	
infectious	agents	of	burn	wounds.	The	AGC	reduced,	to	varying	degrees,	the	microorganism’s	
growth,	cell	viability,	and	cellular	metabolism.	This	novel	antimicrobial	compound	shows	
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promising	potential	as	an	effective	option	for	prevention	and	treatment	of	infections	in	burn	
wound	victims	to	avoid	sepsis.		
Introduction	
Burn	Wounds	
Burn	wounds	are	extremely	different	from	other	wounds,	to	the	point	that	a	separate	medical	
specialty	has	been	designed	to	manage	them.		Heat	from	burns	not	only	damages	skin	locally,	
but	also	causes	generalized	effects	on	the	body.	The	degree	of	the	burn	has	an	enormous	
influence	on	how	life-threatening	the	situation	is	(12).	Acute	burn	wounds	are	a	complex	and	
evolving	injury,	and	extensive	burns	produce	systemic	consequences.	Any	adult	burn	over	15%	
and	pediatric	burn	over	10%	will	produce	a	hypovolemic	shock	due	to	the	increase	in	capillary	
permeability	resulting	in	an	extensive	loss	of	plasma	and	whole	blood	loss.	Burns	can	involve	all	
layers	of	skin	as	well	as	structures	that	are	beneath	such	as	muscle,	bone,	blood	vessels,	nerves,	
and	hair	follicles	(13).	Burn	wounds	are	classified	into	three	different	categories:	first-degree	
burn,	second-degree	burn,	and	third	degree	burn.	In	first-degree	burns,	or	epithelial	burns,	the	
skin	is	erythematic	without	vesication.	Second-degree	burns	involve	the	epidermis	with	variable	
thickness	of	the	dermis.	Second-degree	burns	can	be	further	divided	into	second-degree	
superficial	and	second-degree	deep.	Second-degree	superficial	burns	have	visible	vesication	
and	inflammation,	but	only	on	the	superficial	portion	of	the	dermis.	Second-degree	deep	burns	
penetrate	the	deep	reticular	dermis	where	eschar	formation	is	seen.	Third-degree	burns,	or	full	
thickness	burns,	produce	eschar	(12).	Eschar	is	normally	a	dry,	dark	scab	or	dead	skin	shedding.	
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Physicians	and	other	healthcare	personnel	are	more	involved	with	the	treatment	of	patients	
with	burn	wounds	than	any	other	traumatic	wound.		
	
Microorganisms	Associated	with	Burn	Wounds	
Bacterial	colonization	reaches	as	high	as	86.6%	of	the	isolates	within	the	first	week	of	infection.	
Gram-negative	microorganisms	are	more	predominant;	however,	Staphylococcus	aureus	is	the	
most	prevalent	organism	in	the	first	week	following	the	burn	and	is	about	30%	of	the	bacterial	
isolates	(7).	By	the	third	week,	Staphylococcus	aureus	is	closer	to	10%	of	isolates	while	
Psuedomonas	aeruginosa	reaches	about	30%	of	the	isolates.	This	demonstrates	how	crucial	it	is	
to	treat	a	burn	wound	according	to	the	specific	microorganism(s)	that	colonize	it	because	
microorganisms	have	different	growth	patterns.	Thus,	contamination	of	the	burn	wound	is	the	
guideline	rather	than	an	exception	in	burn	wounds	(7).	Biofilms	can	become	established	within	
wounds	in	5	hours	and	mature	by	10	hours;	therefore,	the	faster	the	wound	acquires	
medication	the	better	the	outcome	for	the	individual	(6,	8).	Burn	patients	are	at	an	extremely	
high	risk	for	infection,	and	about	75%	of	all	burn	wound	deaths	are	related	to	infection	(10).	
Staphylococcus,	Streptococcus,	Pseudomonas,	Acinetobacter,	Escherichia,	Candida,	Citrobacter,	
and	Klebsiella	are	common	causative	agents	of	burn	wound	infections	with	increasing	
resistance	to	many	antimicrobial	medications.	For	instance,	Streptococcus	pyogenes	was	the	
most	frequent	cause	of	burn	wound	infections,	which	induced	sepsis,	early	in	the	last	century.	
As	of	now,	Staphylococcus	aureus	and	Psuedomonas	aeruginosa	have	become	the	most	
frequent	isolated	organisms	from	wounds	caused	by	burns	due	to	their	ability	to	effectively	
evade	certain	medical	treatments	(7).		
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Current	Treatments	for	Infected	Burn	Wounds	
Since	ancient	time,	local	and	systemic	remedies	have	been	used	for	burn	wounds.	Death	
associated	with	extensive	burns	is	mainly	due	to	wound	infection	as	the	patient	becomes	
immunocompromised	from	the	burn	(12).	The	gels	that	exist	today	do	fight	infection	to	
decrease	the	number	of	deaths	caused	by	burns,	but	with	increasing	difficulty	due	to	
resistance.	One	gel,	Aloe	vera	inner	gel,	has	made	an	astonishing	impact	as	it	can	be	used	as	an	
antimicrobial,	anti-inflammatory,	lipid	and	glucose	lowering	agent,	and	has	antioxidant	
functions.	This	gel	showed	remarkable	inhibition	of	H.	Pylori	and	E.	Coli	strains	(1).	Next	Science	
Wound	Gel	Technology	(NxtSc),	is	another	topical	agent	that	is	designed	to	kill	planktonic	
bacteria,	but	this	gel	also	can	penetrate	biofilms	and	kill	the	bacteria	within.	It	works	against	
various	bacterial	infections	that	can	lead	to	life	threatening	sepsis.	The	NxtSc	has	proven	to	
inhibit	the	growth	of	S.	aureus	and	P.	aeruginosa	in	infected	wounds	and	eliminates	other	
gram-positive	and	gram-negative	organisms	from	infected	wounds	(8).	Guar	gum	is	a	new	
antimicrobial	peptide	delivery	system	that	helps	fight	against	diabetic	foot	ulcers,	which	was	
distinguishable	in	its	ability	to	fight	against	Staphlococcus	aureus	in	these	foot	ulcers	(11).	Non-
aqueous	glycerol	monolaurate	gel	(GML)	is	another	gel	that	fights	Staphlococcus	aureus	
infections	and	is	useful	as	a	potent	antibacterial	and	anti-inflammatory	compound	for	
infections.	GML	is	time-dependent	when	removing	biofilms,	with	higher	concentrations	acting	
at	earlier	time	periods	(14).	Chitosan,	a	cationic	natural	polymer,	can	be	used	to	prevent	and	
treat	burn	wounds	because	of	its	ability	to	deliver	extrinsic	antimicrobial	agents	to	the	site	of	
infection	and	its	natural	antimicrobial	properties	(4).	Some	synthetic	skin	substitutes	that	aid	in	
the	antimicrobial	healing	process	include	Duoderm,	Omniderm,	Epigard,	Biobrane,	and	
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Dermagraft.	Commonly	known	topical	antimicrobial	antibiotics	include	Mafenide	acetate,	
Bacitracin,	and	Neosporin	(3).		Other	types	of	interventions	include	burn	wound	dressings	to	
treat	superficial	and	partial	thickness	burns.	These	dressings	range	from	hydrocolloid	and	
polyurethane	dressings	to	hydrogel	and	silicon-coated	dressings	(13).	Though	these	are	all	
excellent,	their	effects	are	becoming	nonexistent	due	to	certain	resistant	bacteria.	We	present	
here,	an	antimicrobial	gel	compound	(AGC)	that	affects	microorganisms	commonly	associated	
with	burn	wounds.	This	new	compound	has	proven	to	eliminate,	or	inhibit,	specific	microbial	
growth	of	microorganisms	such	as	Escherichia	coli,	Candida	albicans,	Citrobacter	freundii,	
Klebsiella	pneumoniae,	Pseudomonas	aeruginosa,	Serratia	marcescens,	and	Enterobacter	
cloacae.	AGC	not	only	decreased	the	microbial	cell	density	and	metabolism,	but	also	decreased	
the	CFU’s	on	LB	agar	plates.		
	
Materials	and	Methods	
Strains	&	Culture	Conditions		
Bacteria	utilized	for	experiments	are	listed	in	Table	1.	All	bacterial	strains	were	purchased	from	
American	Type	Culture	Collection	(ATCC).	Media	for	propagation	and	experiments	involving	
these	strains	was	LB	Miller	broth	(LB),	a	10%	(w/v)	AGC	broth	with	LB,	or	on	LB	agar	plates.		
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Microorganism	 ATCC	
strain		
Type	of	
microorganism	
Gram	
reaction	
Oxygen	
requirement	
Biofilm	
Former	
Candida	albicans	
	
10213	 Eukaryote	 N/A	 Facultative	
anaerobe	
	
Yes	
Citrobacter	freundii	 8090	 Prokaryote	 Negative	 Facultative	
anaerobe	
	
Yes	
Enterobacter	
cloacae	
23355	 Prokaryote	 Negative	 Facultative	
anaerobe	
	
Yes	
Escherichia	coli	 25922	 Prokaryote	 Negative	 Facultative	
anaerobe	
	
Yes	
Klebsiella	
pneumoniae	
13883	 Prokaryote	 Negative	 Facultative	
anaerobe	
	
Yes	
Pseudomonas	
aeruginosa	
10145	 Prokaryote	 Negative	 Facultative	
aerobe 
	
Yes	
Serratia	
marcescens	
13880	 Prokaryote	 Negative	 Facultative	
anaerobe	
	
Yes	
Table	1.	Strains	used	in	experiments	
	
Minimum	Inhibitory	Concentration	(MIC)	and	Minimum	Bactericidal	Concentration	(MBC)	
Strains	were	inoculated	in	LB	broth	for	18	hours,	at	37⁰C,	with	shaking	(255rpm).	These	seed	
cultures	were	used	to	inoculate,	into	varying	concentrations	of	AGC-LB	broth	(0%-10%	w/v),	at	
a	final	concentration	of	1x106	cells/ml.	These	tubes	were	then	incubated	an	additional	24	
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hours.	The	MIC	was	determined	visually	by	the	lack	of	turbidity.	Once	the	MIC	was	determined	
aliquots	from	all	AGC-LB	broth	tubes	were	plated	onto	LB	agar	plates.	MBC	was	determined	as	
the	lowest	percentage	plate	that	was	void	of	growth.	
	
Growth,	Metabolism,	and	Viability	Inhibition	Assay	
Strains	were	inoculated	into	LB	broth	for	18	hours,	at	37⁰C,	with	shaking	(255rpm).	These	seed	
cultures	were	then	used	to	inoculate	LB	broth	(control)	or	10%	AGC-LB	broth	(experimental)	at	
a	final	concentration	of	1x106	cells/ml.	These	tubes	were	then	incubated	an	additional	24	hours	
with	shaking	(255rpm).	The	cultures	were	added	(100µl)	to	96	well	plate	rows.	Rows	1-6	were	
used	to	measure	the	optical	density	(OD600)	measurements	of	growth.	Rows	7-12	were	used	for	
optical	density	(OD570)	measurements	of	metabolism	of	MTT.	Briefly,	5µg/ml	of	MTT	was	added	
to	wells	7-12	and	incubated	at	37⁰C	for	30	minutes.	Acidic	Isopropanol	was	added	to	stop	the	
reaction	and	optical	density	was	then	determined.	Controls	of	LB	broth	only	and	10%	AGC-LB	
only	(no	bacteria)	were	also	added	to	the	96	well	plate	and	treated,	as	above,	to	correct	for	
background	and	to	act	as	a	control.	For	determination	of	cell	viability	each	condition	was	
serially	diluted,	plated	on	LB	agar,	and	colony	forming	units	(CFU)	were	enumerated.	
	
Results	and	Discussion		
AGC	shows	varying	inhibitory	MICs	on	bacteria	commonly	associated	with	burn	wounds.	
The	minimum	inhibitory	concentration	(MIC)	is	the	lowest	concentration	of	an	antimicrobial	
that	will	inhibit	the	visible	growth	of	bacteria	after	incubation.	Of	the	microorganisms	tested	
the	concentration	of	bacterial	cells	grown	with	AGC	was	reduced	when	compared	to	the	
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bacterial	growth	in	the	LB	broth	(0%	AGC)	control	(Table	2).	Candida	albicans	and	Citrobacter	
freundii	displayed	the	lowest	MIC	at	3%	AGC-LB	broth	concentrations.	Serratia	marscescens	
demonstrated	less	turbidity	when	compared	to	the	0%	control.	However,	there	was	growth	in	
all	of	the	concentrations	of	AGC	tested	(0-10%);	therefore,	MIC	was	not	determined.	
Enterobacter	cloacae	(4%),	Escherichia	coli	(6%),	Klebsiella	pneumoniae	(6%),	and	Pseudomonas	
aeruginosa	(5%)	all	had	varying	MICs	(Table	2).	There	appears	to	be	no	defining	characteristic	
that	correlates	with	MIC	among	the	tested	microorganisms	as	there	are	representatives	of	
prokaryotes	and	eukaryotes,	morphology,	Gram	classification,	and	oxygen	requirements	(Table	
1).	Additional	work	by	our	research	group	has	shown	that	Staphylococcus	aureus	is	highly	
susceptible	to	the	inhibitory	effects	of	the	AGC	(data	not	shown).		
	
AGC	does	not	appear	to	have	a	cidal	effect	from	the	MBC	concentrations	tested.	
The	minimum	bactericidal	concentration	(MBC)	is	the	lowest	concentration	of	an	antibacterial	
medication	required	to	kill	a	specific	bacterial	strain.	Only	one	of	the	microorganisms	tested,	
Escherichia	coli	at	9%	AGC,	had	a	detectable	MBC	(Table	3).	All	other	microorganisms	had	
detectable	growth	when	plated	at	all	concentration	dilutions,	though	growth	was	reduced.	This	
observation	provides	two	possible	explanations:	(1)	That	AGC	has	bacteriostatic	effects	on	
microorganisms	and	inhibits	only	growth,	becasue	there	is	no	true	MBC	within	the	10	
concentrations	tested;	therefore,	AGC	may	only	serve	as	a	compound	that	inhibits	growth;	(2)	
that	an	increased	percentage	of	AGC-LB	is	needed	to	determine	the	MBC.	This	potential	
explanation	may	be	considered	in	future	experiments,	however,	we	have	only	been	successful	
in	a	maximum	15%	(w/v)	AGC	to	LB	broth	formulation.	Above	this	percentage,	the	AGC	does	
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not	suspend	in	the	LB	broth.	Additionally,	rule-of-thumb	for	experiments	is	that	the	vehicle	
(AGC)	does	not	contribute	more	than	10%	of	the	total	volume.	This	takes	into	account	effects	
that	any	gel	compound	would	impose	on	bacterial	growth	due	to	limiting	the	bacteria’s	normal	
requirements	of	growth	(i.e.	oxygen	requirements).	
	
AGC	inhibits	microorganism	growth,	cell	metabolism,	and	cell	viability.	
Using	the	information	from	the	MIC	and	MBC	experiments,	it	was	determined	that	the	optimal	
concentration	for	further	experiments	examining	the	microorganism’s	growth,	cellular	
metabolism,	and	cell	viability	would	be	10%	AGC.	A	high	throughput	96-well	plate	assay	was	
developed	to	allow	for	testing	of	all	three	conditions	simultaneously.	Microorganisms	were	
inoculated	(1x106	cells/ml)	and	incubated	overnight	in	LB	broth	with	or	without	10%	AGC.	These	
cultures	were	then	aliquoted	equally	into	rows	of	96-well	plates.	Wells	1-6	were	used	to	obtain	
optical	density	(OD600)	readings	for	growth	analysis.	Wells	7-11	were	used	to	obtain	optical	
density	(OD570)	readings	for	the	reduction	of	MTT	to	formazan,	to	measure	cell	metabolism.	
Well	12	was	untreated	and	used	to	serially	dilute	the	sample	and	plate	on	LB	agar	to	enumerate	
CFU	data,	to	measure	cell	viability.	In	regards	to	optical	density,	or	microbial	growth	density,	all	
microorganisms	tested	in	the	presence	of	10%	AGC	displayed	significant	reduction	in	optical	
density	(Figure	1).		Escherichia	coli	and	Citrobacter	freundii	had	the	largest	decreases	in	optical	
density,	92%	and	75%	reduction	respectively,	as	compared	to	their	controls,	whereas,	Candida	
albicans	had	the	smallest	decrease	in	optical	density	growth,	29%.		Optical	density	readings	
only	identify	the	density	of	growth	based	on	turbidity.	Optical	density	cannot	identify	the	state,	
alive	or	dead,	of	the	cells	contained	within	the	solution.	We	therefore	turned	our	attention	to	
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CFU	methods	of	determining	the	state	of	the	microorganisms.	Samples	of	each	of	the	microbial	
growth,	with	and	without	10%	AGC,	were	used	to	dilute	out	and	plate	on	LB	agar	plates.	In	
theory,	a	single	viable,	alive,	microorganism	has	the	ability	to	grow	into	a	colony.	Once	colonies	
are	enumerated	they	can	be	compared	between	control	and	experimental	conditions.	The	
bacterial	growth	on	LB	plates	differed	tremendously	between	the	AGC	treated	microbes	and	
the	LB	only	microbes	(see	Table	4	for	representative	photographs).	Bacterial	growth	on	the	
plates	containing	the	LB	broth	with	bacteria	had	growth	up	to	dilutions	of	109,	but	the	plates	
containing	AGC	treated	bacteria	were	inhibited	and	most	of	the	growth,	if	any,	was	not	found	
above	dilution	of	103		(Table	4).	All	microorganisms	tested	displayed	decreased	CFUs	in	
comparison	to	their	untreated	controls.	In	contrast	to	the	optical	density	growth	results,	
Klebsiella	pneumoniae	had	the	largest	decrease	in	CFUs	at	90%.	Candida	albicans	and	
Escherichia	coli,	which	had	the	largest	optical	density	growth	decrease	had	a	more	moderate	
CFU	decrease	of	59%	and	57%,	respectively.	This	indicates	that	while	Candida	and	Escherichia	
are	initially	able	to	grow,	shown	by	the	increase	in	optical	density,	the	AGC	inhibits	or	damages	
the	cells,	thus	a	decrease	in	viable	cells	to	produce	colony	forming	units	is	seen.	Pseudomonas	
aeruginosa,	41%,	and	Serratia	marscescens,	35%,	had	the	smallest	decreases	in	CFU.	This	
correlates	with	the	original	MIC	and	MBC	data,	in	that,	the	AGC	for	these	two	microorganisms,	
in	general,	only	inhibits	their	growth.	The	last	assay	performed,	MTT	reduction,	tells	us	more	
about	the	metabolism	and	viability	of	the	microorganisms	when	treated	with	AGC.	The	yellow	
compound	MTT	is	reduced	by	actively	metabolizing	bacteria,	via	their	mitochondria,	to	produce	
a	purple	colored,	reduced	compound.	The	optical	spectra	can	then	measure	the	amount	of	
reduced	product	and	when	compared	to	viable	untreated	controls,	can	give	information	as	to	
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the	metabolic	activity	of	microorganisms.	The	cellular	metabolism	results	were	dramatic,	with	
all	microorganisms	having	significant	reductions	in	the	ability	to	reduce	the	measured	
compound.	The	metabolism	of	the	bacteria	not	containing	the	AGC	exhibited	little	to	no	
inhibition,	whereas	the	bacterial	sample	containing	the	gel	caused	the	cells	metabolism	to	
come	to	a	near	halt	with	very	little	activity	(Figure	3).	However,	as	significant	as	these	results	
were,	we	had	some	interesting	observations	with	this	assay.	When	the	MTT	was	added	to	the	
AGC	only	control	(no	microorganisms	present)	we	observed	an	almost	immediate	purple	color	
change.	As	this	control	is	absent	of	bacteria,	there	should	not	have	been	a	color	change.	The	
MTT	assay	is	based	on	a	reducing	reaction	and	there	are	a	number	of	compounds	and	elements	
that	make	up	the	AGC	that	have	reducing	activates.	Therefore,	we	cannot	accurately	draw	any	
conclusions	from	this	experiment	on	the	viability	of	the	microorganisms	in	regards	to	their	
metabolic	activity.	Further	experiments	will	need	to	be	conducted	with	different	ingredients	of	
the	AGC,	which	cause	reducing	activity,	removed	so	that	better	conclusions	can	be	made	as	to	
viability	in	regards	to	metabolism.	
	
Conclusion	
About	2	million	fires	are	reported	every	year	in	the	United	States,	resulting	in,	1.2	million	
people	burned.	In	patients	with	severe	burns,	which	cover	more	than	40%	of	the	total	body	
surface	area	(TBSA),	75%	of	deaths	are	currently	related	to	sepsis	from	burn	wound	infection,	
other	infection	complications,	and/or	inhalation	injury	(2).	There	are	many	bacteria	that	
colonize	burn	wounds	that	can	potentially	lead	to	septic	shock	and	death	such	as,	
Staphylococcus,	Pseudomonas,	Acinetobacter,	Escherichia,	Candida,	Citrobacter,	and	Klebsiella;	
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which	are	becoming	more	resistant	to	antimicrobial	medications.		Due	to	this	increased	
resistance	in	microorganisms	to	current	medications	and	treatments,	a	new	treatment	method	
is	essential.	The	AGC	examined	in	this	study	shows	ability	to	reduce	growth	and	viability	of	a	
variety	of	microorganisms	commonly	associated	with	burn	wound	infections.	The	activity	of	the	
AGC,	at	this	point,	can	best	be	categorized	as	a	bacteriostatic,	growth	inhibiting,	agent.	This	
inhibition	is	apparent	in	the	low	MIC	ranges,	but	continued	growth	during	the	MBC	ranges	that	
were	tested	was	seen.	Supporting	this,	CFUs,	albeit	low	for	some	bacteria	were	still	present	
when	using	the	highest	concentration	of	AGC,	10%,	tested.	The	results	of	these	tests	indicate	
that	AGC	could	potentially	be	a	powerful	tool	for	the	prevention	of	infection	of	burn	wounds	or	
be	used	to	inhibit	infected	burn	wound	growth	by	microorganisms.	If	AGC	is	truly	a	
bacteriostatic	compound	it	may	not	elicit	the	selective	pressure	on	microorganisms	to	develop	
drug	resistance.	In	this	case,	AGC	could	prove	to	be	a	potentially	lifesaving	treatment	for	those	
individuals	suffering	from	burn	wounds.	
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Microorganism	 0%								1%							2%							3%							4%							5%								6%								7%									8%									9%	 MIC	
Candida	
albicans	
	
3%	
Citrobacter	
freundii	
	
3%	
Enterobacter	
cloacae	
	
4%	
Escherichia	coli	
	
6%	
Klebsiella	
pneumoniae	
	
6%	
Pseudomonas	
aeruginosa	
	
5%	
Serratia	
marscescens	
	
*	
Table	2.	Determination	of	the	MIC	of	bacteria	associated	with	burn	wounds	when	exposed	to	
varying	concentrations	of	AGC.	
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Microorganism	 	 MBC	
Candida	
albicans	
	
>10%	
	
Citrobacter	
freundii	
	
>10%	
	
Enterobacter	
cloacae	
	
>10%	
	
Escherichia	coli	
	
9%	
	
Klebsiella	
pneumoniae	
	
>10%	
	
Pseudomonas	
aeruginosa	
	
>10%	
	
Serratia	
marscescens	
*	 >10%	
	
Table	3.	Determination	of	MBC	of	bacteria	associated	with	burn	wounds	when	exposed	to	
varying	concentration	of	AGC.	
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Figure	1.	Optical	density	(OD600)	graph	of	microorganism	growth	with	or	without	10%	AGC.	
Standard	deviation	bars	shown.	
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Microorganism	 Control	(No	AGC)	
	
Experimental		
(10%	AGC)	
	
Candida	
albicans	
*	 *	
Citrobacter	
freundii	 	 	
Enterobacter	
cloacae	
	 	
Escherichia	coli	 *	 *	
Klebsiella	
pneumoniae	
	 	
Pseudomonas	
aeruginosa	
	 	
Serratia	
marscescens	 	
	
Table	4.	CFU	determination	of	microorganisms	without	AGC	and	with	AGC	
 19 
	
Figure	2.	Logarithmic	graph	of	CFU	experiments	of	microorganisms	grown	with	or	without	
10%	AGC.	
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Figure	3.	Graph	of	cell	respiration	using	MTT	assay	on	microorganisms	grown	with	or	without	
10%	AGC.	Standard	deviation	bars	shown.		
	
	
	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 21 
Acknowledgements	
	
	
	 I	would	like	to	thank	Dr.	W.	Andrew	Clark	for	providing	AGC,	which	he	invented.	His	
contributions	allowed	us	to	conduct	our	experiments.	I	would	also	like	to	thank	Dr.	Andrew	
Clark,	Dr.	Sean	Fox,	and	Olivia	Egen	for	agreeing	to	be	the	readers	of	my	thesis.	I	am	grateful	
that	Dr.	Ranjan	Chakraborty	and	the	Department	of	Health	Science	at	East	Tennessee	State	
University	(ETSU)	let	us	use	their	lab	to	perform	our	experiments.	I	would	like	to	thank	the	
Midway	Honors	Program	for	giving	me	the	opportunity	to	attend	ETSU	and	improve	my	
knowledge	in	Health	Science.	Most	of	all,	I	am	thankful	for	Dr.	Sean	Fox	for	permitting	me	to	
join	his	research	team.	In	my	desperate	time	of	need	of	a	thesis	mentor,	Dr.	Fox	took	on	the	
challenge	of	completing	my	honors	thesis	in	just	one	semester.	We	both	knew	that	this	
objective	would	not	be	easy,	but	with	his	intelligence,	compassion,	and	time	management	skills,	
our	goal	was	accomplished.	 
	
	 	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
 22 
References	
	
1. Cataldi,	V.,	Bartolomeo,	S.,	Campli,	E.,	Nostro,	A.,	&	Cellini,	L.	(2015,	July).	In	vitro	
activity	of	Aloe	vera	inner	gel	against	microorganisms	grown	in	planktonic	and	sessile	
phases.	International	Journal	of	Immunopathology	and	Pharmacology,	28(4),	595-602.	
2. Church,	D.,	Elsayed,	S.,	Reid,	O.,	Winston,	B.,	&	Lindsay,	R.	(2006).	Burn	Wound	
Infections.	Clinical	Microbiology	Reviews,	19(2),	403–434.	
http://doi.org/10.1128/CMR.19.2.403-434.2006	
3. Dai,	T.,	Huang,	Y.-Y.,	Sharma,	S.	K.,	Hashmi,	J.	T.,	Kurup,	D.	B.,	&	Hamblin,	M.	R.	(2010).	
Topical	Antimicrobials	for	Burn	Wound	Infections.	Recent	Patents	on	Anti-Infective	Drug	
Discovery,	5(2),	124–151.		
4. Dai,	T.,	Tanaka,	M.,	Huang,	Y.-Y.,	&	Hamblin,	M.	R.	(2011).	Chitosan	preparations	for	
wounds	and	burns:	antimicrobial	and	wound-healing	effects.	Expert	Review	of	Anti-
Infective	Therapy,	9(7),	857–879.	http://doi.org/10.1586/eri.11.59	
5. Dua,	K.,	Malipeddi,	V.	R.,	Madan,	J.,	Gupta,	G.,	Chakravarthi,	S.,	Awasthi,	R.,	…	De	Jesus	
Andreoli	Pinto,	T.	(2016).	Norfloxacin	and	metronidazole	topical	formulations	for	
effective	treatment	of	bacterial	infections	and	burn	wounds.	Interventional	Medicine	&	
Applied	Science,	8(2),	68–76.	http://doi.org/10.1556/1646.8.2016.2.4		
6. Ferro,	V.	A.,	Bradbury,	F.,	Cameron,	P.,	Shakir,	E.,	Rahman,	S.	R.,	&	Stimson,	W.	H.	
(2003).	In	Vitro	Susceptibilities	of	Shigella	flexneri	and	Streptococcus	pyogenes	to	Inner	
Gel	of	Aloe	barbadensis	Miller.	Antimicrobial	Agents	and	Chemotherapy,	47(3),	1137–
1139.	http://doi.org/10.1128/AAC.47.3.1137-1139.2003	
7. Macedo,	Jefferson	Lessa	Soares	de,	&	Santos,	João	Barberino.	(2005).	Bacterial	and	
fungal	colonization	of	burn	wounds.	Memórias	do	Instituto	Oswaldo	Cruz,	100(5),	535-
539.	https://dx.doi.org/10.1590/S0074-02762005000500014	
8. Miller,	K.	G.,	Tran,	P.	L.,	Haley,	C.	L.,	Kruzek,	C.,	Colmer-Hamood,	J.	A.,	Myntti,	M.,	&	
Hamood,	A.	N.	(2014).	Next	Science	Wound	Gel	Technology,	a	Novel	Agent	That	Inhibits	
Biofilm	Development	by	Gram-Positive	and	Gram-Negative	Wound	
Pathogens.	Antimicrobial	Agents	and	Chemotherapy,	58(6),	3060–3072.	
http://doi.org/10.1128/AAC.00108-14		
9. Mueller,	E.	A.,	&	Schlievert,	P.	M.	(2015).	Non-Aqueous	Glycerol	Monolaurate	Gel	
Exhibits	Antibacterial	and	Anti-Biofilm	Activity	against	Gram-Positive	and	Gram-Negative	
Pathogens.	PLoS	ONE,	10(3),	e0120280.	http://doi.org/10.1371/journal.pone.0120280		
10. Mundhada	SG,	Waghmare	PH,	Rathod	PG,	Ingole	KV.	Bacterial	and	fungal	profile	of	burn	
wound	infections	in	Tertiary	Care	Center.	Indian	J	Burns	2015;	23:71-75.	Available	from:	
http://www.ijburns.com/text.asp?2015/23/1/71/171661	
11. Santos,	R.,	Gomes,	D.,	Macedo,	H.,	Barros,	D.,	Tibério,	C.,	Tavares,	L.,	&	Castanho,	M.	
(2016,	October	18).	Guar	gum	as	a	new	antimicrobial	peptide	delivery	system	against	
diabetic	foot	ulcers	Staphylococcus	aureus	isolates.	Journal	of	Medical	Microbiology.	
12. Tiwari,	V.	K.	(2012).	Burn	wound:	How	it	differs	from	other	wounds?	Indian	Journal	of	
Plastic	Surgery :	Official	Publication	of	the	Association	of	Plastic	Surgeons	of	India,	45(2),	
364–373.	http://doi.org/10.4103/0970-0358.101319		
 23 
13. Wasiak	J,	Cleland	H,	Campbell	F,	Spinks	A.	Dressings	for	superficial	and	partial	thickness	
burns.	Cochrane	Database	of	Systematic	Reviews	2013,	Issue	3.	Art.	No.:	CD002106.	DOI:	
10.1002/14651858.CD002106.pub4.	
14. Yang,	C.,	Chowdhury,	M.	.	A.	K.,	Hou,	Y.,	&	Gong,	J.	(2015).	Phytogenic	Compounds	as	
Alternatives	to	In-Feed	Antibiotics:	Potentials	and	Challenges	in	
Application.	Pathogens,	4(1),	137–156.	http://doi.org/10.3390/pathogens4010137		
 
 
